Of importance, the MAGE family member B2 (MAGEB2) was found to be significantly upregulated in a group of HNSCC patients characterised by their lack of response to conventional treatment (CDDP and/or radiotherapy). Here, MAGEB2 is linked to head and neck squamous cell carcinoma.